Herts and Essex Fertility - IVF Spot Purchase NCL ICB

The NHS North Central London Integrated Care Board (ICB) has awarded a contract under the Health Care Services (Provider Selection Regime) Regulations 2023 for the provision of in vitro fertilisation services. The procurement process, identified as "Herts and Essex Fertility - IVF Spot Purchase NCL ICB," falls under the services category and is classified within the healthcare sector. This contract has been specifically awarded to HERTS and ESSEX FERTILITY CENTRE LIMITED, located in Cheshunt, United Kingdom, with the contract becoming active as of 12th November 2025.

The procurement method used was a direct award procedure without prior publication, indicating it was outside the typical EU procurement directives. The procurement stage is described as complete, reflecting that the award stage has been finalised. This tender presents significant business opportunities, particularly for organisations specialising in healthcare services and in vitro fertilisation.

Given the specific nature of the services, businesses with expertise in fertility treatments and patient-centric healthcare offerings are ideally positioned to compete and succeed in similar future contracts. The direct award process highlights the need for businesses to establish strong reputations and relationships within the healthcare procurement ecosystem to enhance their chances of being considered as suppliers in comparable situations. As the procurement was conducted under the Provider Selection Regime, suppliers may also benefit from understanding this regulatory framework to align their offerings accordingly.